Dr. Tamar Gabelaya, MD

Dr. Gabelaya practices at Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital.

Dr. Gabelaya's NPI, 1588697395, was assigned on July 8, 2006. Dr. Gabelaya holds Georgia license 64375.

Dr. Gabelaya's primary practice is Northside Hospital Atlanta, at 1000 Johnson Ferry Road, NE, Atlanta, GA 30342 in Fulton County. The practice phone is (404) 851-8000.

Dr. Gabelaya's primary practice is Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital. Dr. Gabelaya is also affiliated with Northside Hospital Gwinnett. The medical group on file is Emory Healthcare. Dmand AI also links Dr. Gabelaya to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gabelaya practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Gabelaya's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Gabelaya's licenses on file in 2 states: Georgia and Iowa.

CMS data shows 268 Medicare services from Dr. Gabelaya across 4 procedure codes in 2024, for 111 Medicare patients. Medicare paid $20,774 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 111 Medicare patients who saw Dr. Gabelaya in 2024. The largest group is 75 to 84, with 38 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 3.16, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gabelaya's median patient age at 69, with 56% women.

In 2024, Dr. Gabelaya wrote 260 Medicare Part D claims for 57 patients. 81% of them were for generic drugs. CMS names the drug for 87 of them, across 5 drugs with 11 or more claims each, at $12,014 in total drug cost. In 2023, CMS named 138 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Gabelaya for performance year 2024, reported through an alternative payment model (APM). Dr. Gabelaya accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 45 general payments to Dr. Gabelaya from 11 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $244.